Objective-Early clinical presentation of ST-segment-elevation myocardial infarction (STEMI) and non-ST-segmentelevation myocardial infarction affects patient management. Although local inflammatory activities are involved in the onset of MI, little is known about their impact on early clinical presentation. This study aimed to investigate whether local inflammatory activities affect early clinical presentation. Approach and Results-This study comprised 94 and 17 patients with MI (STEMI, 69; non-STEMI, 25) and stable angina pectoris, respectively. We simultaneously investigated the culprit lesion morphologies using optical coherence tomography and inflammatory activities assessed by shedding matrix metalloproteinase 9 (MMP-9) and myeloperoxidase into the coronary circulation before and after stenting. Prevalence of plaque rupture, thin-cap fibroatheroma, and lipid arc or macrophage count was higher in patients with STEMI and non-STEMI than in those with stable angina pectoris.
M yocardial infarction (MI) has been redefined by The Joint
European Society of Cardiology/American College of Cardiology Committee. 1 New entities, ST-segment-elevation MI (STEMI) and non-ST-segment-elevation MI (NSTEMI), were introduced into the clinical field. This introduction has a huge clinical impact on treatment strategies of patients with MI. 1 Therefore, researchers have since vigorously investigated what factors determine the clinical presentation of STEMI or NSTEMI.
Classical thought proposes that complete vessel occlusion with thrombus generates STEMI, whereas an incomplete vessel occlusion results in NSTEMI. 2 Several imaging studies have recently demonstrated that detailed plaque morphologies were different between STEMI and NSTEMI. [2] [3] [4] These morphological differences are thought to be contributing to the development of total or subtotal thrombus formation.
In contrast, accumulating evidences have revealed that acute coronary syndrome (ACS) is associated with increased systemic and local inflammatory responses. [5] [6] [7] [8] Localized overexpression of matrix metalloproteinase 9 (MMP-9) and myeloperoxidase was frequently found in coronary plaques with vulnerable features. [9] [10] [11] In addition, several clinical studies found a significant elevation of circulating MMP-9 and myeloperoxidase levels after angioplasty in patients with coronary artery diseases, indicating the release of MMP-9 and myeloperoxidase from coronary plaques into the coronary circulation. 12, 13 Importantly, the elevation of circulating MMP-9 and myeloperoxidase levels was independent of myocardial necrosis in patients with ACS. 14, 15 Therefore, local inflammatory activity is thought to have some impact on early clinical presentation. However, no studies have addressed the impact of in vivo local inflammatory activities on the early clinical presentation in patients with acute MI.
The aim of this study was to investigate whether local inflammatory activities have impact on the early clinical presentation and plaque morphologies.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement. . CAD indicates coronary artery disease; CCB, calcium channel blocker; CK-MB, creatine kinase myocardial band; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; Hs-CRP, high sensitive C reactive protein; LDL-C, low-density lipoprotein cholesterol; NSTEMI, non-ST-segmentelevation myocardial infarction; RAS-I, renin-angiotensin system inhibitor; SAP, stable angina pectoris; STEMI, STsegment-elevation myocardial infarction; T-CHO, total cholesterol; and TG, triglyceride.
Nonstandard Abbreviations and Acronyms
*Compared between STEMI and NSTEMI.
Results

Patient Characteristics
Patient characteristics are summarized in Table 1 . Smoking habit and medications were different between the 3 groups.
Angiographic and Percutaneous Coronary Intervention Findings
Angiographic and percutaneous coronary intervention findings are summarized in Table 2 . Initial TIMI (Thrombolysis In Myocardial Infarction) flow grade 0 or 1 was seen more often in patients with STEMI than in those with NSTEMI and stable angina pectoris (SAP; STEMI, 74% versus NSTEMI, 36%; SAP, 0%; P<0.01). The reference diameter in quantitative coronary analysis was similar between groups. Percent stenosis (STEMI, 94.9±8.8% versus NSTEMI, 87.5±9.1% versus SAP, 70.4±5.3%; P<0.01) and minimum lumen diameter (STEMI, 0.15±0.26 mm versus NSTEMI, 0.37±0.29 mm versus SAP, 0.84±0.24 mm; P<0.01) were different between groups ( Figure 1 ). Thrombus aspiration is performed to reduce thrombus burden. B, Coronary blood sampling with an aspiration catheter immediately after thrombus aspiration. C, Part of MMP-9 in a culprit plaque is released into the coronary circulation by stent implantation. D, Coronary sampling repeats after stent implantation.
Optical Coherence Tomographic Findings
Optical coherence tomographic (OCT) findings are summarized in Table 3 . Red thrombus was frequently observed in STEMI compared with others (P<0.01). The lipid arc and prevalence of plaque rupture (PR) and thin-cap fibroatheroma were significantly different between the 3 groups (P<0.01). Although the prevalence of PR was similar between STEMI and NSTEMI in post hoc analysis, the prevalence of proximal-type PR was significantly higher in STEMI (STEMI, 59% versus NSTEMI, 16%; P=0.03). Representative cases are shown in Figure 2 .
Inflammatory Assessment
Local inflammatory activities were significantly higher than systemic in both MMP- Figure 3 shows the comparison of MMP-9 and myeloperoxidase levels between STEMI, NSTEMI, and SAP groups. Patients with STEMI had significantly elevated systemic (P<0.01), prestent local (P<0.01), and poststent local MMP-9 levels (P<0.01). No significant difference was observed in systemic and local myeloperoxidase levels. Figure 4 shows MMP-9 and myeloperoxidase levels between PR and non-PR. Prestent local MMP-9 levels were significantly elevated in PR (P<0.01) immediately after thrombus aspiration, whereas prestent local myeloperoxidase levels were higher in non-PR (P=0.04). When we compared MMP-9 levels between acute MI and SAP limited with patients with non-PR, they were significantly elevated in patients with acute MI at all timing (systemic: acute MI, 46.6 [33.9-62.7] ng/mL 
Multivariate Analysis for Determinants of STEMI
Multivariate analysis results are summarized in Table 4 . Among the variables, poststent local MMP-9 and the presence of red thrombus are the independent determinants for STEMI (MMP-9 [per 100 ng/mL]: odds ratio, 3.577; 95% confidence interval, 1.412-9.057; P<0.01; red thrombus: odds ratio, 5.147; 95% confidence interval, 1.456-18.083; P=0.01).
Local MMP-9 for Long-Term Outcomes
The Kaplan-Meier curve presents that patients with high poststent local MMP-9 level (≥115 ng/mL) are associated with poorer outcomes (P=0.02; Figure 5 ).
Discussion
To the best of our knowledge, this is the first study that investigated culprit plaque morphology and local inflammatory activities simultaneously to clarify the determinant factors for the early clinical presentation of STEMI. The main findings are as follows: (1) local MMP-9 and myeloperoxidase levels were elevated compared with the systemic levels, (2) systemic and local MMP-9 levels were significantly higher in patients with STEMI than in those with NSTEMI or SAP, (3) local MMP-9 level and red thrombus on OCT were the independent determinants for STEMI based on multivariate analysis. 
Local MMP-9 and STEMI
The difference between STEMI and NSTEMI is speculated to primarily come from the formation of totally or subtotally occlusive thrombus. Previous studies reported that thrombus characteristics are also associated with clinical presentation. 16, 17 Red thrombus is more prevalent in patients with acute MI, whereas white thrombus is frequently found in patients with non-ST-segment-elevation ACS. 16 We also confirmed that red thrombus was more frequent in STEMI.
Red thrombus is formed with red blood cells and inflammatory leukocytes entrapped by fibrin through activating the coagulation cascade. 18 The coagulation system is mainly regulated by the balance between tissue factor and tissue factor pathway inhibitor. 18 MMP-9 cleaves the tissue factor pathway inhibitor and causes function loss. 19 Therefore, local MMP-9 indirectly enhances tissue factor activity, resulting in the formation of thrombogenic features. 19, 20 Abundant local MMP-9 could cause massive red thrombosis resulting in STEMI, whereas other plaques shedding small amounts of MMP-9 may cause less red thrombosis, resulting in NSTEMI. The thin-cap fibroatheroma rupture is known to be the leading mechanism of both STEMI and NSTEMI. 21 The prevalence of PR in the present study was similar in STEMI and NSTEMI, suggesting that the underlying mechanism seems to be identical between STEMI and NSTEMI. The result was consistent with those from previous intravascular ultrasound studies. 4, 22 However, detailed plaque morphology by OCT was different between STEMI and NSTEMI. Proximal-type PR was more frequently observed in STEMI. In proximal-type rupture, it is conceivable that antegrade flow enters the cavity and stirs the lipid component, leading to more of the thrombogenic contents exposed to blood, compared with other rupture types. This exposure of the plaque contents including MMP-9 may result in more rapid red thrombus formation and total occlusion of the coronary artery.
Many studies demonstrated that myeloperoxidase was associated with the onset of ACS. 23, 24 A previous study by Ferrante et al 11 demonstrated a link between high myeloperoxidase levels and the presence of plaque erosion, which was one of the nonrupture ACS etiologies. The local myeloperoxidase levels in nonrupture plaque in our study were higher than those in PR immediately after thrombus aspiration. High myeloperoxidase levels would be associated with the onset of nonrupture ACS, resulting in poorer prognosis. However, a previous study trial clearly showed that serum myeloperoxidase level was not associated with clinical presentation in patients with acute MI, 14 which was consistent with our results.
Many factors could be involved in the development of STEMI. Multiple logistic regression analysis showed that plaque inflammatory substrate, such as local MMP-9, was the key factor for early clinical presentation. Plaque inflammatory substrate would be more important for development of STEMI than simple plaque morphology.
Clinical Implication
The marker that seems most accurate for early clinical presentation is MMP-9 (whether it is systemic or local), whereas myeloperoxidase is clearly more elevated locally but seemingly without much distinction according to clinical presentation. Correlation coefficient between systemic and local MMP-9 is modest (r=0.572; P<0.01). Systemic MMP-9 might be compromised by systemic atherosclerosis and various pathological conditions, [25] [26] [27] even though systemic assessment is convenient for clinicians. Therefore, we think that local MMP-9 is more suitable for assessment of coronary-specific inflammatory activity in coronary artery disease. Local inflammatory activity for atherosclerosis needs increased attention.
Despite numerous efforts to identify vulnerable plaques associated with future ACS events, the prediction of ACS is still challenging. A prospective study reported that the annual risk of MI or cardiovascular death from thin-cap fibroatheroma was <0.5%, and the value was similar to that of intimal thickening, 28 indicating that focusing on simple plaque morphology is insufficient to predict future ACS events. Plaques with abundant shedding of MMP-9 are likely to cause severe clinical events such as STEMI. Local MMP-9 assessment could help identify truly high-risk plaques. Furthermore, high local MMP-9 levels have an impact on long-term outcome. Local MMP-9 assessment might thus contribute to patient management. However, we obtained coronary blood from the distal of culprit site. Patients with acute MI often have subclinical PRs apart from the culprit site. 29 Our local MMP-9 levels might still be compromised by the nonculprit vulnerable plaques. Therefore, our concept should be confirmed by further investigations measuring the inflammatory markers in nonculprit vessels or performing upstream and downstream measurements for a series of plaques in the same vessel by a new device, ie, a liquid biopsy catheter (PlaqueTec, Cambridge, United Kingdom).
Limitations
The present study had several limitations. First, our study protocol might potentially have a selection bias. We excluded patients with NSTEMI who did not undergo emergent coronary angiography and stent implantation within 6 hours from symptom onset. Therefore, the included patients with NSTEMI became much lesser than that with STEMI. Second, even when manual thromboaspiration was carefully performed in patients, procedure-related alteration of culprit lesion morphology was still possible and could induce procedure-related PR and influence the direction of the rupture cavity. Although thrombus volume or characteristics would be critical factors to the clinical presentation, we did not perform pathological assessments on the aspirated thrombus. In addition, sampling after stenting might affect results. Plaque embolization may possibly have already occurred, and local levels might not correctly reflect local inflammation and composition. Although no statistical difference was observed in final TIMI flow grade between the groups, coronary flow or residual thrombus might affect the results. Third, intracoronary thrombus might affect OCT analysis. Some PR might be invisible because of the presence of thrombus and misdiagnosis as non-PR. Finally, the lack of assessment for plaque volume is a crucial limitation of the OCT study. Patients with STEMI showed smaller lumen diameters and greater % stenoses in quantitative coronary analysis, suggesting that the plaque volume of STEMI might be larger than that of others. Large plaques may potentially comprise more MMP-9.
Conclusion
Local MMP-9 level could determine the early clinical presentation in patients with acute MI. Local MMP-9 would be more important for development of STEMI than simple plaque morphology. More attention should be paid for local inflammatory activity for atherosclerotic lesions.
